Changes in oropharyngeal colonization and infection by Candida albicans in human immunodeficiency virus-infected patients

被引：15
作者：
Dios, PD
Ocampo, A
Otero, I
Iglesias, I
Martínez, C
机构：
[1] Univ Santiago de Compostela, Sch Med & Dent, Santiago De Compostela, Spain
[2] Xeral Cies Hosp, Vigo, Spain
来源：
JOURNAL OF INFECTIOUS DISEASES | 2001年 / 183卷 / 02期
关键词：
D O I：
10.1086/317920
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：355 / 356
页数：2
相关论文
共 10 条
[1]   In vitro and in vivo anticandidal activity of human immunodeficiency virus protease inhibitors [J].
Cassone, A ;
De Bernardis, F ;
Torosantucci, A ;
Tacconelli, E ;
Tumbarello, M ;
Cauda, R .
JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (02) :448-453
[2]   Elevated aspartic proteinase secretion and experimental pathogenicity of Candida albicans isolates from oral cavities of subjects infected with human immunodeficiency virus [J].
DeBernardis, F ;
Chiani, P ;
Ciccozzi, M ;
Pellegrini, G ;
Ceddia, T ;
DOffizzi, G ;
Quinti, I ;
Sullivan, PA ;
Cassone, A .
INFECTION AND IMMUNITY, 1996, 64 (02) :466-471
[3]   Frequency of oropharyngeal candidiasis in HIV-infected patients on protease inhibitor therapy [J].
Dios, PD ;
Ocampo, A ;
Miralles, C ;
Otero, I ;
Iglesias, I ;
Rayo, N .
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 1999, 87 (04) :437-441
[4]   Failure of indinavir to inhibit Candida albicans in vitro [J].
Dios, PD ;
Varela, IO ;
Martín, II ;
Hermida, AO ;
Vázquez, CM .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1999, 18 (10) :755-756
[5]  
DIOS PD, 1993, STOMA LISBON, V29, P43
[6]   Association of plasma levels of human immunodeficiency virus type 1 RNA and oropharyngeal Candida colonization [J].
Gottfredsson, M ;
Cox, GM ;
Indridason, OS ;
de Almeida, GMD ;
Heald, AE ;
Perfect, JR .
JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (02) :534-537
[7]   Dissimilar attenuation of Candida albicans virulence properties by human immunodeficiency virus type 1 protease inhibitors [J].
Gruber, A ;
Berlit, J ;
Speth, C ;
Lass-Florl, C ;
Kofler, G ;
Nagl, M ;
Zepelin, MB ;
Dierich, MP ;
Wurzner, R .
IMMUNOBIOLOGY, 1999, 201 (01) :133-144
[8]  
Klein RS, 2000, J INFECT DIS, V181, P812, DOI 10.1086/315290
[9]   Effects of the human immunodeficiency virus (HIV) proteinase inhibitors saquinavir and indinavir on in vitro activities of secreted aspartyl proteinases of Candida albicans isolates from HIV-Infected patients [J].
Korting, HC ;
Schaller, M ;
Eder, G ;
Hamm, G ;
Böhmer, U ;
Hube, B .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (08) :2038-2042
[10]   In vivo analysis of secreted aspartyl proteinase expression in human oral candidiasis [J].
Naglik, JR ;
Newport, G ;
White, TC ;
Fernandes-Naglik, LL ;
Greenspan, JS ;
Greenspan, D ;
Sweet, SP ;
Challacombe, SJ ;
Agabian, N .
INFECTION AND IMMUNITY, 1999, 67 (05) :2482-2490
1